Skip to main content
YIFAN PHARMACEUTICAL CO.,LTD logo

YIFAN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002019 ISIN · CNE000001K65 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,497 across all filing types
Latest filing 2025-01-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002019

About YIFAN PHARMACEUTICAL CO.,LTD

https://www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and commercialization of innovative biologics, specialty small molecules, and traditional Chinese medicine. The company maintains a diverse product portfolio, notably featuring Ryzneuta (efbemalenograstim alfa), a long-acting recombinant human granulocyte colony-stimulating factor used to treat chemotherapy-induced neutropenia. It is also recognized as a major global supplier of Vitamin B5 (D-calcium pantothenate). Operating with a global perspective, the firm manages integrated R&D and production platforms that adhere to international quality standards. Its core activities span drug discovery, clinical development, and large-scale manufacturing, with a strategic emphasis on therapeutic areas such as oncology, hematology, and dermatology.

Recent filings

Filing Released Lang Actions
独立董事候选人关于参加最近一期独立董事培训并取得相关证明的承诺函
Board/Management Information Classification · 95% confidence The document is a letter of commitment from an independent director candidate regarding participation in a training program and obtaining a certification recognized by the Shenzhen Stock Exchange. It relates to board member qualifications and governance practices but does not contain financial data, audit information, or report content. It is not an announcement of a report, nor a financial or regulatory filing in the strict sense. The content fits best under Board/Management Information (MANG) as it concerns a board member's status and commitments.
2025-01-14 Chinese
关于独立董事辞职及补选独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director and the election of a new independent director. It details the circumstances of the resignation, the process for electing a replacement, and the qualifications of the new director. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-01-14 Chinese
第八届董事会第十五次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions from the company's board of directors meeting, including the resignation and nomination of independent directors, and the calling of a shareholders meeting. It contains no financial statements or detailed financial data. It is a formal disclosure about board/management changes and meeting decisions. The document length is short (1877 characters) and it is clearly a meeting resolution announcement rather than a full report or financial filing. Therefore, it fits best under Board/Management Information (MANG).
2025-01-14 Chinese
独立董事候选人声明与承诺
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes multiple attestations about the candidate's qualifications, independence, compliance with laws and regulations, and commitments to fulfill the role responsibly. There are no financial statements, no discussion of company financial performance, no voting results, no meeting materials, and no mention of report publication or regulatory filings. The content is focused on board/management information specifically related to the nomination and qualifications of a board member candidate. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is about 5,028 characters, which is consistent with a detailed declaration rather than a brief announcement or a full report.
2025-01-14 Chinese
独立董事提名人声明与承诺
Board/Management Information Classification · 100% confidence The document is a formal statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations and commitments regarding the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and contains substantive content related to management changes rather than a brief announcement or regulatory filing.
2025-01-14 Chinese
关于控股子公司产品获巴西国家卫生监督局批准上市的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its subsidiary's product receiving approval from the Brazilian National Health Surveillance Agency (ANVISA) for market launch. It discusses the product's registration details, the significance of the approval, and potential impact on the company. There are no financial statements, earnings data, or detailed financial analysis. The document is relatively short (980 characters) and serves as a regulatory announcement about product approval and market expansion. It does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a voting result, management change, or legal proceeding. The best fit is a Regulatory Filing (RNS) as it is a general regulatory announcement about product approval and market entry, which does not fit other specific categories.
2024-12-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.